Les Prix Stevie® annoncent les lauréats de la 19e édition des International Business Awards® du monde entier

3 700 candidatures ont été présentées par des organisations de 67 pays

Gagnants des International Business Awards

Des entreprises et dirigeants de haut niveau du monde entier ont été élus lauréats des Prix Stevie® d’or, d’argent et de bronze dans le cadre des 19e International Business Awards® annuels.

FAIRFAX, Virginie, 16 août 2022 (GLOBE NEWSWIRE) — Des entreprises et dirigeants de haut niveau du monde entier ont été élus lauréats des Prix Stevie® d’or, d’argent et de bronze dans le cadre des 19e International Business Awards® annuels, le seul programme international de récompenses pour les entreprises.

Les lauréats ont été sélectionnés parmi plus de 3 700 candidatures soumises par des organisations établies dans 67 pays.

Une liste complète de tous les lauréats des Prix Stevie d’or, d’argent et de bronze 2022 par catégorie est disponible à l’adresse www.StevieAwards.com/IBA.

Cette année, plus de 300 cadres à travers le monde ont été membres de 11 jurys de sélection des gagnants des Stevies.

Le plus grand vainqueur des Stevies d’or, d’argent et de bronze est HALKBANK d’Istanbul, en Turquie, avec 32 prix. Les autres lauréats des nombreux Prix Stevie incluent IBM Corporation (21), LLYC (20), Deutsche Post DHL (19), Abu Dhabi Ports Group (17), Viettel Group (17), OPET (15), Telkom Indonesia (13), ZER (13), Ayala Land Inc. (12), Ooredoo (12), Globe Telecom (10), PJ Lhuillier, Inc (PJLI) (10), Enerjisa Enerji (9), Wolters Kluwer (9), Strategic Public Relations Group (8), pH7 Communications (8), Tata Consultancy Services Inc. (8), Adfactors PR (8), Jeunesse Global (7), Bank of Montreal, (6), Canadian Tire Corporation (6), HeyMo The Experience Design Company (6), Octopus Energy (6), Sleepm Global Inc. (6), VUMI Group (6) et VNPT VinaPhone Corporation (6).

IBM, une société technologique multinationale basée à Armonk, NY, aux États-Unis, a remporté neuf Prix Stevie d’or, plus que toute autre organisation du concours.

Toutes les entreprises du monde peuvent participer aux IBA et peuvent soumettre leurs candidatures dans un large éventail de catégories récompensant les réussites dans des domaines tels que la gestion, le marketing, les relations publiques, le service à la clientèle, les ressources humaines, les nouveaux produits et services, les technologies, les sites Web, les applications, les événements, et bien plus.

Les prix seront remis lors d’un gala organisé à Londres, en Angleterre, le 15 octobre 2022.

À propos des Prix Stevie
Les Prix Stevie sont décernés dans huit programmes : les Prix Stevie en Asie-Pacifique, les Prix Stevie en Allemagne, les Prix Stevie au Moyen-Orient et en Afrique du Nord, les American Business Awards®, les International Business Awards®, les Prix Stevie pour les grands employeurs, les Prix Stevie pour les femmes entrepreneurs et les Prix Stevie pour les ventes et le service à la clientèle. Les concours des Prix Stevie reçoivent chaque année plus de 12 000 nominations émanant d’entreprises de plus de 70 pays. En récompensant les entreprises de tous types et de toutes tailles, ainsi que leurs collaborateurs, les Stevies reconnaissent les performances exceptionnelles sur le lieu de travail dans le monde entier. Pour en savoir plus sur les Prix Stevie, veuillez consulter le site http://www.StevieAwards.com.

Contact Marketing
Nina Moore
Nina@StevieAwards.com
+1 (703) 547-8389

Une photo accompagnant ce communiqué de presse est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/bea1d991-4f7d-41b6-bce7-4ba3619ac4ab/fr

Prosecuting a president is divisive and sometimes destabilizing – here’s why many countries do it anyway

Criminal prosecution of former President Donald Trump and his allies could result from at least one of multiple investigations.

These include the Aug. 8, 2022, seizure of documents from his Florida home by the FBI, continued progress in a Georgia state investigation into Republican election tampering and the ongoing revelations of evidence presented by the congressional committee investigating the Jan. 6 insurrection.

While charging a former president with a criminal offense would be a first in the United States, in other countries ex-leaders are routinely investigated, prosecuted and even jailed.

In March 2021, former French President Nicolas Sarkozy was sentenced to a year in prison for corruption and influence peddling. Later that year, the trial of Israel’s longtime Prime Minister Benjamin Netanyahu related to breaches of trust, bribery and fraud while in office commenced. And Jacob Zuma, the former president of South Africa who was charged with money laundering and racketeering, will likely face trial in May 2023 after years of delays.

At first glance, prosecuting current or past top officials accused of illegal conduct seems like an obvious decision for a democracy: Everyone should be subject to the rule of law.

But presidents and prime ministers aren’t just anyone. They are chosen by a nation’s citizens or their parties to lead. They are often popular, sometimes revered. So judicial proceedings against them are inevitably perceived as political and become divisive.

Destabilizing prosecutions

This is partly why U.S. President Gerald Ford pardoned Richard Nixon, his predecessor, in 1974. Despite clear evidence of criminal wrongdoing in the Watergate scandal, Ford feared the country “would needlessly be diverted from meeting (our) challenges if we as a people were to remain sharply divided over” punishing the ex-president.

Public reaction at the time was divided along party lines. Today, some now see absolving Nixon as necessary to heal the nation, while others believe it was a historic mistake, even taking Nixon’s deteriorating health into account – if for no other reason than it emboldens future impunity of the kind Trump is accused of.

Our research on prosecuting world leaders finds that both sweeping immunity and overzealous prosecutions can undermine democracy. But such prosecutions pose different risks for older democracies such as France and the U.S. than they do in younger democracies like South Africa.

Mature democracies

Strong democracies are usually competent enough – and the judicial system independent enough – to prosecute politicians who misbehave, including top leaders.

Sarkozy is France’s second modern president to be found guilty of corruption, after Jacques Chirac in 2011 for kickbacks and an attempt to bribe a magistrate. The country didn’t fall apart after either conviction. Some observers, however, say that Sarkozy’s three-year prison sentence was too harsh and politically motivated.

In mature democracies, prosecutions that hold leaders accountable can solidify the rule of law. South Korea investigated and convicted five former presidents starting in the 1990s, a wave of political prosecutions that culminated in the 2018 impeachment of President Park Geun-hye and, soon after, the conviction and imprisonment of her predecessor, Lee Myung-bak.

Did these prosecutions deter future leaders from wrongdoing? For what it’s worth, Korea’s two most recent presidents have so far kept out of legal trouble.

Overzealous prosecution versus rule of law

Even in mature democracies, prosecutors or judges can abuse prosecutions. But overzealous political prosecution is more likely, and potentially more damaging, in emerging democracies where courts and other public institutions may be insufficiently independent from politics. The weaker and more beholden the judiciary, the easier it is for leaders to exploit the system, either to expand their own power or to take down an opponent.

Brazil embodies this dilemma.

Ex-President Luiz Inácio “Lula” da Silva, a former shoeshine boy turned popular leftist, was jailed in 2018 for accepting bribes. Many Brazilians thought his prosecution was a politicized effort to end his career.

A year later, the same prosecutorial team accused the conservative former President Michel Temer of accepting millions in bribes. After his term ended in 2019, Temer was arrested; his trial was later suspended.

Both Brazilian presidents’ prosecutions were part of a yearslong sweeping anti-corruption probe by the courts that has jailed dozens of politicians. Even the probe’s lead prosecutor is accused of corruption.

Depending on one’s perspective, Brazil’s crisis reveals that nobody is above the law or that the government is incorrigibly corrupt – or both. With such confusion, it becomes easier for politicians and voters to view leaders’ transgressions as a normal cost of doing business.

For Lula, a conviction didn’t end his career. He was released from jail in 2019 and the Supreme Court later annulled his conviction. Lula is now leading the 2022 presidential race against current Brazilian President Jair Bolsonaro.

Stability versus accountability

Historically, Mexico has taken a different approach to prosecuting past presidents: It doesn’t.

During the 20th century, Mexico’s ruling Institutional Revolutionary Party, or PRI, established a system of patronage and corruption that kept its members in power and other parties in the minority. While making a show of going after smaller fish for petty indiscretions, the PRI-run legal system wouldn’t touch top party officials, even the most openly corrupt.

Impunity kept Mexico stable during its transition to democracy in the 1990s by placating PRI members’ fears of prosecution after leaving office. But government corruption flourished, and with it, organized crime.

That may be changing, though. In early August 2022, Mexican federal prosecutors confirmed that it has several open investigations into former PRI President Enrique Peña Nieto for alleged money laundering and election-related offenses, among other crimes.

Mexico is far from the only country to overlook the bad deeds of past leaders. Our research finds that only 23% of countries that transitioned to democracy between 1885 and 2004 charged former leaders with crimes after democratization.

Protecting authoritarians – including those who oversaw human rights violations – may seem contrary to democratic values, but many transitional governments have decided it is necessary for democracy to take root.

That’s the bargain South Africa struck as apartheid’s decades of segregation and human rights abuses ended in the early 1990s. South Africa’s white-dominated government negotiated with Nelson Mandela’s Black-led African National Congress to ensure outgoing government members and supporters would avoid prosecution and largely retain their wealth.

This strategy helped the country transition to majority Black rule in 1994 and avoid a civil war. But it hurt efforts to create a more equal South Africa. As a result, the country has retained one of the world’s highest racial wealth gaps.

Corruption is a problem, too, as former President Zuma’s prosecution for lavish personal use of public funds shows. But South Africa has a famously independent judiciary. Despite pushback from some African National Congress stalwarts and several legal appeals, Zuma’s prosecution continues. And it may yet deter future misdeeds.

How mature is mature?

Israel is partly a testament to the rule of law – and partly a cautionary tale about prosecuting leaders in democracies.

Israel didn’t wait for Prime Minister Benjamin Netanyahu to leave office to investigate wrongdoing. But the court process was fraught with delays, in part because Netanyahu used state power to resist what he called a “witch hunt.”

The trial triggered protests by his Likud party. Netanyahu tried unsuccessfully to secure immunity and stall. He was even reelected while under indictment, and his trial is not over yet.

If Trump is criminally prosecuted, the process would reveal something fundamental about American democracy. Whatever the outcomes, they would be a matter of both law – and politics.

Source: The Conversation Media Group Ltd

The key to treating TB may be in a common carbohydrate. What we know so far

Curdlan is a popular carbohydrate in the food industry. Its name is derived from the word “curdle”, and as it suggests, it’s widely used as a thickener and stabiliser in everything from sausages to milk substitutes.

More recently, it has caught the eye of the pharmaceutical industry. That’s because curdlan, itself produced by bacteria, is able to trigger an antibacterial response in a range of environments and organisms. Among other uses, researchers are looking at curdlan as a possible treatment for cancers and other diseases.

One of those diseases is tuberculosis (TB), the infection responsible for killing more people than any other infectious disease in human history. South Africa has one of the world’s highest TB burdens – along with 29 other countries including India and China. These countries contribute 86% of the globe’s 10 million annual TB cases. South Africa’s combined burden of TB, TB/HIV and multi-drug resistant TB (MDR-TB), driven by socioeconomic factors and its high HIV numbers, is especially worrying.

Existing remedies made up of cocktails of antibiotics are not effective against MDR-TB. This has sparked interest in finding alternative treatments. It’s why our research group at the School of Pharmacy at the University of the Western Cape, and others, are beginning to test the efficacy of curdlan as a potential drug candidate.

In a recent paper, for instance, we show very promising results for the potential treatment of TB using curdlan-based nanoparticles.

How TB infects

Our work centres on developing host-directed therapies using curdlan. Such treatments essentially let the human immune system do the heavy lifting. This is done by activating its natural antibacterial mechanisms while controlling the inflammation that results from such activation. Inflammation is a signal that the immune system is working. But if inflammation is out of control it can cause major damage to human tissue, as seen in severe COVID-19 infections.

Research has already shown that host-directed therapies hold immense potential for the treatment of TB.

To understand how these therapies work, it’s important to understand how TB infection unfolds in the human body.

Primary TB infection occurs when a person inhales aerosol droplets, released by contagious individuals, that contain Mycobacterium tuberculosis (M.tb). This is the bacterium that causes TB. Once inhaled, M.tb quickly makes its way to the lung’s alveolar space, made up of tiny air sacs that sit at the end of the bronchioles, which are the air passages inside the lungs.

Here it is absorbed by what’s known as alveolar macrophages, the lung cells that are usually the first line of defence against pollutants and pathogenic organisms. Typically these macrophages would trigger an immune response in the body. But M.tb has evolved so cannily that it eludes or switches off this immune-triggering response in the macrophages. These alveolar macrophages become its infection headquarters; the bacterium remains concealed within these cells.

For any treatment to be successful, it has to navigate a host of obstacles to reach M.tb. It must make its way through complex lung lesions, then penetrate the cell membrane of macrophages and other host cells, and finally be taken up by the M.tb sitting within these cells.

That’s where nanoparticles enter the picture.

Tiny ‘snipers’

Nanoparticles are extremely small. They range from between one to 100 nanometres; for some perspective, there are a million nanometres in a single millimetre. In theory, and as is being shown in laboratories and existing treatments for other conditions like cancer, nanotherapies allow drugs to target pathogens with sniper-like accuracy. They also have the potential to tackle patient non-compliance that can lead to drug resistant TB.

The reasons for non-compliance are varied and complex, but the duration of the therapy itself is a factor. Existing treatments require that, depending on the severity and progress of the disease, patients take many drugs over as many as six months. The course of treatment for MDR-TB lasts up to 24 months.

This high pill load, together with sometimes toxic side effects, has been shown to overwhelm patients. Many do not return to clinics and hospitals for check-ups, especially when they feel better after a few weeks. Some stop taking their medication. This could be behind the rise of drug resistant strains. Such non-compliance is also believed to be the cause of South Africa’s comparatively high TB mortality.

Traditional drugs are taken orally or intravenously. They travel throughout the body via the blood circulatory system. Many drug molecules do not reach their targets, staying in the body where they cause several negative side effects. That’s where nanoparticle-based treatments have the upper hand: they are extremely targeted and their release into the system is very controlled. Smaller doses are required and there is less dispersion around the body, meaning fewer side effects.

Promising findings

All these factors suggest that nanoparticle-based treatments may be the right approach to take against TB. And two interesting findings from our study bolster the case.

One, we observed the production of what’s known as pro-inflammation cytokines, a signalling molecule that triggers an antibacterial effect in immune cells. This meant that the nanoparticles were doing what they were meant to do.

Secondly, we found that the M.tb bacteria in the immune cells were considerably reduced over a 72-hour period.

These results suggest that curdlan nanotherapeutics are an avenue worth exploring in treating TB. There is much more work to be done, but it’s an important step towards tackling TB – in South Africa and everywhere else.

Source: The Conversation Media Group Ltd